|
Methyleugenol in the Diet: Toxic and Pathological Aspects |
|
|
1 | (60) |
|
|
|
|
2 | (1) |
|
|
3 | (1) |
|
General Background Information |
|
|
3 | (8) |
|
|
3 | (1) |
|
|
4 | (5) |
|
|
9 | (1) |
|
Environmental Considerations |
|
|
9 | (1) |
|
Structure, Chemical Identification, and Physical--Chemical Properties |
|
|
10 | (1) |
|
|
11 | (7) |
|
|
12 | (3) |
|
Gastrointestinal System Effects |
|
|
15 | (1) |
|
Central Nervous System Effects |
|
|
15 | (3) |
|
Nonorgan-Directed Toxicity |
|
|
18 | (3) |
|
|
18 | (2) |
|
|
20 | (1) |
|
Food and Water Consumption |
|
|
21 | (1) |
|
|
21 | (26) |
|
|
21 | (1) |
|
|
22 | (5) |
|
Intrahepatic Biliary Pathology |
|
|
27 | (2) |
|
Metabolism and Bioactivation |
|
|
29 | (4) |
|
|
33 | (2) |
|
A Mechanism for MEG-Related Liver Cancer |
|
|
35 | (2) |
|
|
37 | (1) |
|
|
37 | (3) |
|
|
40 | (1) |
|
|
41 | (2) |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
44 | (1) |
|
|
45 | (1) |
|
|
46 | (1) |
|
|
47 | (4) |
|
|
47 | (1) |
|
|
47 | (1) |
|
Chromosomal Recombination |
|
|
48 | (1) |
|
|
48 | (1) |
|
Sister Chromatid Exchange |
|
|
49 | (1) |
|
Unscheduled DNA Synthesis |
|
|
50 | (1) |
|
Morphological Cell Transformation |
|
|
50 | (1) |
|
|
51 | (1) |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
53 | (8) |
|
Methyl Mercury Toxicity: Pharmacokinetics and Toxicodynamic Aspects |
|
|
61 | (24) |
|
|
|
61 | (1) |
|
|
62 | (1) |
|
Methyl Mercury in the Environment |
|
|
62 | (1) |
|
Accumulation in the Food Chain |
|
|
63 | (1) |
|
Residues in Freshwater Fishery and Seafood |
|
|
64 | (1) |
|
Exposure to Methyl Mercury |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
66 | (2) |
|
Pharmacokinetics in Sensitive Subpopulation |
|
|
68 | (1) |
|
Pharmacokinetics in Experimental Animals |
|
|
68 | (3) |
|
Mathematical Models of Transplacental and Lactational Transfer |
|
|
71 | (3) |
|
|
74 | (1) |
|
|
75 | (3) |
|
|
78 | (1) |
|
Risk-Based Guidance Values |
|
|
78 | (1) |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
80 | (1) |
|
|
80 | (5) |
|
Uranium in Food and Water: Actual and Potential Effects |
|
|
85 | (8) |
|
|
|
85 | (1) |
|
|
85 | (1) |
|
Uranium in Drinking Water |
|
|
86 | (2) |
|
|
88 | (1) |
|
Conclusions: Actual and Potential Effects |
|
|
89 | (1) |
|
|
90 | (3) |
|
Polychlorinated Biphenyls, Oxidative Stress, and Diet |
|
|
93 | (36) |
|
|
|
|
|
|
|
94 | (1) |
|
|
94 | (5) |
|
Polychlorinated Biphenyls |
|
|
94 | (2) |
|
|
96 | (1) |
|
PCBs, Fatty Acids, and Vitamins and Minerals |
|
|
96 | (3) |
|
Oxidative Stress and PCBs |
|
|
99 | (5) |
|
Oxidative Stress through Receptor Binding and Gene Regulation |
|
|
99 | (1) |
|
Metabolic Activation of Lower Halogenated Biphenyls |
|
|
100 | (2) |
|
ROS Production by PCB Metabolites |
|
|
102 | (2) |
|
Generation of Oxidative Stress: Implication in Carcinogenesis |
|
|
104 | (4) |
|
PCB-induced Oxidative DNA Damage In Vitro |
|
|
104 | (1) |
|
ROS Production, GSH Depletion, and Cytotoxicity in Cells in Culture |
|
|
105 | (1) |
|
PCBs Produce a Decrease in the Levels of Vitamin E and GSH |
|
|
106 | (1) |
|
PCB Exposure Reduces Selenium Levels by Yet Unknown Mechanisms |
|
|
107 | (1) |
|
PCBs Repress the Selenium-dependent GSH Peroxidase in the Liver |
|
|
107 | (1) |
|
PCBs and Diet --- Implications in Cardiovascular Disease |
|
|
108 | (4) |
|
Endothelial Toxicity of Coplanar PCBs |
|
|
109 | (1) |
|
Coplanar PCBs and Proinflammatory Events |
|
|
109 | (2) |
|
Dietary Fatty Acids, PCBs, and Endothelial Cell Dysfunction |
|
|
111 | (1) |
|
Premetastatic and Atherogenic Effects of Ortho-Substituted, Noncoplanar PCB Congeners |
|
|
112 | (5) |
|
Involvement of the Vascular Endothelium in Blood-Borne Cancer Metastasis |
|
|
112 | (2) |
|
Role of ortho-Chlorine-Substituted, Noncoplanar PCB Congeners in Cancer Metastasis and Atherogenesis |
|
|
114 | (3) |
|
Diet and Protection against PCB-Induced Cytotoxicity |
|
|
117 | (2) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
119 | (2) |
|
|
121 | (1) |
|
|
121 | (1) |
|
|
122 | (7) |
|
Oxidized Products of Cholesterol: Toxic Effects |
|
|
129 | (36) |
|
|
|
|
|
|
129 | (1) |
|
|
130 | (1) |
|
|
130 | (2) |
|
Oxysterol Identification and Measurement |
|
|
132 | (4) |
|
Origin of Oxysterols In Vivo |
|
|
136 | (4) |
|
Proapoptotic Effect of Oxysterols |
|
|
140 | (6) |
|
|
141 | (1) |
|
Effect on Nonvascular Cells |
|
|
142 | (1) |
|
Mechanism of Induction of Apoptosis by Oxysterols |
|
|
143 | (1) |
|
The Cytotoxicity of Oxysterols Is Quenched When They Are in a Mixture |
|
|
144 | (2) |
|
Proinflammatory Effect of Oxysterols |
|
|
146 | (4) |
|
Mechanisms Underlying the Proinflammatory Effect of Oxysterols |
|
|
148 | (1) |
|
Antioxidants May Prevent Both Exogenous and Endogenous Oxysterol Generation |
|
|
148 | (2) |
|
|
150 | (2) |
|
|
152 | (1) |
|
|
152 | (1) |
|
|
152 | (13) |
|
Adverse Effects and Toxicity of Nutraceuticals |
|
|
165 | (32) |
|
|
|
|
|
166 | (1) |
|
|
166 | (4) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
167 | (1) |
|
|
168 | (1) |
|
Problems with Formulated Products |
|
|
169 | (1) |
|
Carnitine and Acetyl-L-Carnitine |
|
|
170 | (4) |
|
|
171 | (1) |
|
Adverse Effects and Toxicity |
|
|
172 | (1) |
|
|
173 | (1) |
|
|
174 | (5) |
|
Mechanisms of Action of Soy Isoflavones |
|
|
174 | (1) |
|
|
175 | (3) |
|
|
178 | (1) |
|
|
179 | (2) |
|
Toxicity and Adverse Effects |
|
|
180 | (1) |
|
|
181 | (4) |
|
|
181 | (3) |
|
Toxic Effects and Drug Interactions |
|
|
184 | (1) |
|
|
185 | (2) |
|
|
185 | (1) |
|
|
186 | (1) |
|
|
187 | (1) |
|
|
187 | (1) |
|
|
188 | (1) |
|
|
188 | (9) |
|
Safety Concerns of Genetically Modified Foods |
|
|
197 | (24) |
|
|
|
197 | (3) |
|
Potential Dangers of GM Foods |
|
|
200 | (5) |
|
Risk of Producing Allergenic Foods |
|
|
200 | (2) |
|
Risk of Producing Toxic Food |
|
|
202 | (1) |
|
Risks GM Foods may Pose to Human Populations |
|
|
203 | (1) |
|
Risks GM Foods may Pose to the Environment |
|
|
204 | (1) |
|
Potential Benefits of GM Foods |
|
|
205 | (6) |
|
Producing Foods with Reduced Allergenicity and Lower Toxin Levels |
|
|
205 | (1) |
|
Improving the Nutritional Value of Food |
|
|
205 | (2) |
|
Foods with Medicinal Properties |
|
|
207 | (2) |
|
Foods with Improved Taste |
|
|
209 | (1) |
|
Production of Organic Chemicals Used in Food Production |
|
|
209 | (1) |
|
Reducing the Use of Chemicals in the Growing Process of Foods |
|
|
210 | (1) |
|
Improving Processing and Marketing Qualities of Food |
|
|
210 | (1) |
|
|
211 | (4) |
|
Safety of GM Foods Compared with Food from Non-GM Varieties |
|
|
211 | (1) |
|
Risks Involved with Foods Compared with Pharmaceuticals |
|
|
212 | (1) |
|
|
213 | (1) |
|
|
213 | (1) |
|
|
214 | (1) |
|
|
215 | (1) |
|
|
216 | (1) |
|
|
217 | (4) |
|
Food Contaminants and Children: Cause for Concern |
|
|
221 | (22) |
|
|
|
221 | (1) |
|
|
222 | (1) |
|
Susceptibility of Children |
|
|
222 | (2) |
|
Children's Exposure Rates |
|
|
224 | (1) |
|
Children's Health Hazards |
|
|
224 | (3) |
|
Food Safety Hazards for Children |
|
|
227 | (9) |
|
|
227 | (2) |
|
|
229 | (1) |
|
|
230 | (3) |
|
Inadvertent Chemical Constituents |
|
|
233 | (2) |
|
|
235 | (1) |
|
|
236 | (1) |
|
|
237 | (1) |
|
|
237 | (1) |
|
|
237 | (6) |
|
Celiac Disease: A New Paradigm of an Immune-Mediated Disorder Due to Dietary Gluten |
|
|
243 | (24) |
|
|
|
|
244 | (1) |
|
|
244 | (5) |
|
Classic Gastrointestinal Form |
|
|
245 | (1) |
|
Late-Onset Gastrointestinal Form |
|
|
245 | (1) |
|
|
245 | (1) |
|
The Musculoskeletal System |
|
|
245 | (1) |
|
The Skin and Mucous Membranes |
|
|
246 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
|
247 | (1) |
|
The Central Nervous System |
|
|
247 | (1) |
|
|
248 | (1) |
|
|
248 | (1) |
|
|
249 | (1) |
|
Complications of Celiac Disease |
|
|
249 | (1) |
|
Screening for Celiac Disease with Serum Antibodies |
|
|
250 | (2) |
|
|
250 | (1) |
|
Antiendomysial Antibodies |
|
|
251 | (1) |
|
Tissue Transglutaminase Antibodies |
|
|
252 | (1) |
|
Current Guidelines on the Use of Serology |
|
|
252 | (1) |
|
Definitive Diagnosis with Small Intestinal Biopsy |
|
|
252 | (2) |
|
|
254 | (1) |
|
|
254 | (1) |
|
Treatment of Celiac Disease with the Gluten-Free Diet |
|
|
255 | (3) |
|
|
258 | (1) |
|
|
259 | (8) |
Index |
|
267 | |